NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Pauline Vaflard
Institut Curie - Paris / France
Others
AD Scientific Index ID: 4577860
Curie Institute
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Pauline Vaflard's MOST POPULAR ARTICLES
1-)
Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of phase III trialsE Pons-Tostivint, A Latouche, P Vaflard, F Ricci, D Loirat, S Hescot, ...JCO Precision Oncology 3, 1-10, 2019612019
2-)
Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut CurieC Basse, C Morel, M Alt, MP Sablin, C Franck, G Pierron, C Callens, ...ESMO open 3 (3), e000339, 2018292018
3-)
Prospective evaluation of ultrafast breast MRI for predicting pathologic response after neoadjuvant therapiesT Ramtohul, C Tescher, P Vaflard, J Cyrta, N Girard, C Malhaire, ...Radiology 305 (3), 565-574, 2022292022
4-)
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersSI Labidi-Galy, TLM Rouge, O Derbel, A Wolfer, E Kalbacher, T Olivier, ...Gynecologic oncology 155 (2), 262-269, 2019282019
5-)
Dissociated responses in patients with metastatic solid tumors treated with immunotherapyP Vaflard, X Paoletti, V Servois, P Tresca, E Pons-Tostivint, MP Sablin, ...Drugs in R&D 21, 399-406, 2021162021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept